Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

ClinicalTrials.gov ID: NCT01882439

Public ClinicalTrials.gov record NCT01882439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To examine the safety and efficacy of tofacitinib in subjects with active psoriatic arthritis who have previously had an inadequate response to at least one TNF inhibitor either due to lack of efficacy or an adverse event.

Study identification

NCT ID
NCT01882439
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
395 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2013 (Actual)
Primary completion
Apr 2016 (Actual)
Completion
Apr 2016 (Actual)
Last update posted
Sep 15, 2017

2013 – 2016

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Rheumatology Associates P.C. Birmingham Alabama 35205 —
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801-4414 —
Arizona Arthritis & Rheumatology Associates, P.C. Glendale Arizona 85306 —
Medvin Clinical Research Covina California 91723 —
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Fullerton California 92835 —
Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles California 90095 —
UCLA David Geffen School of Medicine Los Angeles California 90095 —
San Diego Arthritis Medical Clinic San Diego California 92108 —
Stanford Hospital and Clinics Stanford California 94305 —
New England Research Associates, LLC Trumbull Connecticut 06611 —
Rheumatology Associates of Central Florida, PA Orlando Florida 32806 —
Millennium Research Ormond Beach Florida 32174 —
Arthritis Center, Inc. Palm Harbor Florida 34684 —
Integral Rheumatology & Immunology Specialists (IRIS) Plantation Florida 33324 —
Florida Medical Clinic, P.A. Zephyrhills Florida 33542 —
St. Luke's Clinic - Rheumatology Boise Idaho 83702 —
St. Luke's Intermountain Research Center Boise Idaho 83702 —
Bluegrass Community Research, Inc Lexington Kentucky 40504 —
Klein & Associates, M.D., P.A. Hagerstown Maryland 21740 —
The Center For Rheumatology And Bone Research Wheaton Maryland 20902 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
St. Paul Rheumatology, PA Eagan Minnesota 55121 —
Clayton Medical Research St Louis Missouri 63117 —
Physician Research Collaboration, LLC Lincoln Nebraska 68516 —
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756 —
Cincinnati Rheumatic Disease Study Group, Inc. Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Paramount Medical Research & Consulting, LLC Middleburg Heights Ohio 44130 —
East Penn Rheumatology Associates, PC Bethlehem Pennsylvania 18015 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Low Country Rheumatology, PA Charleston South Carolina 29406 —
Arthritis Clinic Jackson Tennessee 38305 —
West Tennessee Research Institute Jackson Tennessee 38305 —
Adriana M. Pop-Moody, M.D., Clinic, P.A. Corpus Christi Texas 78404 —
Pioneer Research Solutions, Inc. Cypress Texas 77429 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Drug Shipment/Storage: Investigational Drug Services Salt Lake City Utah 84112 —
University of Utah Hospital & Clinics Salt Lake City Utah 84132 —
Dynacare Laboratories Seattle Washington 98122 —
Seattle Rheumatology Associates Seattle Washington 98122 —
Swedish Medical Center Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01882439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01882439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →